Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
84.03
+4.10 (5.13%)
At close: May 20, 2026, 4:00 PM EDT
84.16
+0.13 (0.15%)
After-hours: May 20, 2026, 7:56 PM EDT
Globus Medical Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Globus Medical stock has a consensus rating of "Buy" and an average price target of $111.08. The average 1-year stock price forecast is 32.19% higher than the current stock price, while the lowest is $87 (+3.53%) and the highest is $123 (+46.38%).
Price Target: $111.08 (+32.19%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 5 | 5 | 5 |
| Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Hold | 5 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 14 | 14 | 14 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $115 → $120 | Buy | Maintains | $115 → $120 | +42.81% | May 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $104 → $103 | Buy | Maintains | $104 → $103 | +22.58% | May 8, 2026 |
| Needham | Needham | Strong Buy Maintains $114 → $117 | Strong Buy | Maintains | $114 → $117 | +39.24% | May 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $98 → $104 | Buy | Maintains | $98 → $104 | +23.77% | Feb 26, 2026 |
| Barclays | Barclays | Buy Maintains $118 → $123 | Buy | Maintains | $118 → $123 | +46.38% | Feb 25, 2026 |
Financial Forecast
Revenue This Year
3.27B
from 2.94B
Increased by 11.13%
Revenue Next Year
3.48B
from 3.27B
Increased by 6.67%
EPS This Year
4.77
from 3.92
Increased by 21.74%
EPS Next Year
5.22
from 4.77
Increased by 9.42%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.4B | 3.7B | |||
| Avg | 3.3B | 3.5B | |||
| Low | 3.1B | 3.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.1% | 11.8% | |||
| Avg | 11.1% | 6.7% | |||
| Low | 6.5% | 1.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.02 | 5.57 | |||
| Avg | 4.77 | 5.22 | |||
| Low | 4.36 | 4.83 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 28.0% | 16.6% | |||
| Avg | 21.7% | 9.4% | |||
| Low | 11.2% | 1.2% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.